Advisers signaled interest in making available a vaccine made with a technology different from the messenger RNA shots that have dominated the U.S. immunization arsenal against the disease.
Related posts:
Trump to prioritize older adults for Covid vaccines, release all doses
Republicans hit mute on Obamacare wars
Drug industry pushes FDA to solve growing inspection backlog
CDC director: Delta variant is growing threat to unvaccinated people
‘The CDC hasn’t changed’: Biden’s top health officials try to sell new masking guidance
FDA targets early September for approving Pfizer’s Covid-19 vaccine
No ‘clear’ messaging about pandemic from Biden and Trump administrations, Maryland’s governor says
Ire over pharmacy middlemen fuels lobbying blitz
China’s Tianjin testing all residents after Omicron found
The doctor who sees you now may have Covid
Biden administration lays out rules for reimbursing at-home Covid tests
‘Uterus surveillance’: The scramble to keep abortion data from prying eyes
